4.6 Article

Altered expression of the immunoregulatory ligand-receptor pair CD200-CD200R1 in the brain of Parkinson's disease patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Prefrontal Cortex Transcriptomic Deconvolution Implicates Monocyte Infiltration in Parkinson's Disease

Sai Batchu

Summary: Analysis of RNA sequencing data from PD patients' brain tissue revealed significantly higher relative abundances of monocytes in the prefrontal cortices of PD patients compared to controls, while the relative proportions of other immune subtypes showed no significant differences. The findings support previous reports and suggest a potential involvement of monocytes in PD pathogenesis.

NEURODEGENERATIVE DISEASES (2021)

Article Immunology

The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease

Neus Rabaneda-Lombarte et al.

Summary: The study found a correlation between CD200-CD200R1 alterations, glial activation, and neuronal loss, with CD200R1 stimulation reducing MPTP-induced loss of dopaminergic neurons, and CD200 deficiency resulting in earlier microglial activation. This suggests that enhancing CD200R1 signaling is a possible approach to controlling neuroinflammation and neuronal death in PD.

JOURNAL OF NEUROINFLAMMATION (2021)

Article Neurosciences

Validation of Induced Microglia-Like Cells (iMG Cells) for Future Studies of Brain Diseases

Atoshi Banerjee et al.

Summary: This study utilized a microglia-like cellular model derived from peripheral blood monocytes and characterized it through various analyses, showing its similarity to human microglia and unique gene expression. The model is valuable for studying microglial function in various brain diseases, such as schizophrenia and Alzheimer's disease (AD).

FRONTIERS IN CELLULAR NEUROSCIENCE (2021)

Article Neurosciences

The Human Hippocampus in Parkinson's Disease: An Integrative Stereological and Proteomic Study

Sandra Villar-Conde et al.

Summary: This study found that the distribution of alpha-synuclein in the hippocampus of PD patients is not associated with volumetric, neural, or glial changes. Proteomic analysis revealed changes in proteins associated with synaptic structures in the diseased hippocampus, indicating that hippocampal changes occur at the synapse level during PD.

JOURNAL OF PARKINSONS DISEASE (2021)

Article Biochemistry & Molecular Biology

CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein

Tony Valente et al.

CELL DEATH AND DIFFERENTIATION (2020)

Review Clinical Neurology

Microglia and Parkinson's disease: footprints to pathology

Ekaterina Lazdon et al.

JOURNAL OF NEURAL TRANSMISSION (2020)

Article Neurosciences

Microglia and astrocyte dysfunction in parkinson's disease

Tae-In Kam et al.

NEUROBIOLOGY OF DISEASE (2020)

Article Neurosciences

Neuroinflammation and protein pathology in Parkinson's disease dementia

Antonina Kouli et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)

Review Neurosciences

Pharmacological Targeting of Microglial Activation: New Therapeutic Approach

Cai-Yun Liu et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Review Neurosciences

Role of the CD200-CD200R Axis During Homeostasis and Neuroinflammation

Gemma Manich et al.

NEUROSCIENCE (2019)

Article Biochemistry & Molecular Biology

Truncated CD200 stimulates tumor immunity leading to fewer lung metastases in a novel Wistar rat metastasis model

Jun Kuwabara et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Neurosciences

Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages

Tony Valente et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2017)

Article Geriatrics & Gerontology

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease

Sudhakar R. Subramaniam et al.

FRONTIERS IN AGING NEUROSCIENCE (2017)

Article Medicine, Research & Experimental

Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients

Ruben Fernandez-Santiago et al.

EMBO MOLECULAR MEDICINE (2015)

Article Clinical Neurology

In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease

S. Iannaccone et al.

PARKINSONISM & RELATED DISORDERS (2013)

Article Medicine, Research & Experimental

Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease

Adriana Sanchez-Danes et al.

EMBO MOLECULAR MEDICINE (2012)

Article Medicine, Research & Experimental

Inflammation and Adaptive Immunity in Parkinson's Disease

R. Lee Mosley et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Article Biochemistry & Molecular Biology

Altered Regulation of CD200 Receptor in Monocyte-Derived Macrophages from Individuals with Parkinson's Disease

Xiao-Guang Luo et al.

NEUROCHEMICAL RESEARCH (2010)

Article Biochemistry & Molecular Biology

Alternative splicing of CD200 is regulated by an exonic splicing enhancer and SF2/ASF

Zhiqi Chen et al.

NUCLEIC ACIDS RESEARCH (2010)

Review Neurosciences

The influence of microglia on the pathogenesis of Parkinson's disease

Caitriona M. Long-Smith et al.

PROGRESS IN NEUROBIOLOGY (2009)

Article Clinical Neurology

Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions

Nathalie Koning et al.

ANNALS OF NEUROLOGY (2007)

Review Pharmacology & Pharmacy

Inflammatory process in Parkinson's disease: Role for cytokines

T Nagatsu et al.

CURRENT PHARMACEUTICAL DESIGN (2005)

Review Geriatrics & Gerontology

Staging of brain pathology related to sporadic Parkinson's disease

H Braak et al.

NEUROBIOLOGY OF AGING (2003)

Article Multidisciplinary Sciences

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

RM Hoek et al.

SCIENCE (2000)